Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors

Paolo Giovanni Artini, Maria Ruggiero, María Ruggiero, P. Monteleone, Patrizia Monteleone, Angelo Carpi, Francesca Cristello, Vito Cela, Andrea Riccardo Genazzani
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2007 · vol. 62(6) , pp. 373–377 · doi:10.1016/j.biopha.2007.10.005 · PMID:18037256 · W2086071664
article OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

This study investigated the presence and levels of vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Ovarian Diseases Ovarian Neoplasms Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factor Receptor-1 Adult Aged Ascitic Fluid Ascitic Fluid Cystadenocarcinoma Cystadenocarcinoma Cystadenoma Cystadenoma Cyst Fluid Cyst Fluid Endometriosis Endometriosis Female Gene Expression Humans Middle Aged

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

Cited by (3)

References (24)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:42.556217+00:00
License: CC0 · commercial use OK